OTC:ELTP | Cash Flow Statement | ELITE PHARMACEUTICALS INC /NV/

Complete source-backed cash-flow history.

Available history
2010-09-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30$5.91M$252,975.00$10.07M$808,964.00-$808,964.00-$114,594.00
2026-03-31$18.46M$252,077.00$9.15M$398,016.00-$398,016.00-$41,522.00
2025-12-31$18.59M$268,662.00
2025-09-30$13.7M$275,391.00
2025-06-30-$5.88M$275,413.00$14.78M$218,204.00-$218,204.00-$4.13M
2025-03-31$17M$290,392.00$3.92M$754,110.00-$754,110.00-$137,044.00
2024-12-31-$10.89M$313,060.00
2024-09-30-$11.04M$227,356.00
2024-06-30$615,773.00$322,103.00$3.14M$778,527.00-$1.66M-$174,906.00
2024-03-31$3.33M$328,382.00$2.1M$403,646.00-$403,646.00-$400,969.00
2023-12-31$706,354.00
2023-09-30$14.93M
2023-06-30$1.14M$328,282.00-$2.71M$3.96M
2023-03-31-$1.23M$344,091.00$2.97M$536,211.00-$536,211.00-$12.5M
2022-12-31$2.97M
2022-09-30$1.52M
2022-06-30$305,883.00$296,294.00-$557,516.00$94,597.00-$94,597.00$11.9M
2022-03-31$2.43M$300,822.00$1.61M-$264,179.00-$94,244.00
2021-12-31$2.28M
2021-09-30$1.8M
2021-06-30$2.39M$312,702.00$1.72M-$4,950.00-$152,549.00
2021-03-31-$482,623.00$322,986.00-$749,368.00-$184,902.00-$1.29M
2020-12-31$2.01M
2020-09-30$2.48M
2020-06-30$1.08M$327,617.00$807,423.00$37,276.00$811,404.00
2020-03-31$936,368.00$326,709.00-$1.21M-$31,805.00$500,817.00
2019-12-31-$1.86M
2019-09-30-$1.6M
2019-06-30$279,702.00$330,953.00$188,273.00-$2,978.00$114,010.00
2019-03-31-$2.66M$315,103.00-$2.14M$350,000.00$385,072.00
2018-12-31-$2.34M
2018-09-30-$2.58M
2018-06-30-$1.69M$303,711.00-$1.71M-$178,558.00$354,223.00
2018-03-31-$2.83M$289,647.00-$1.01M$101,786.00$847,522.00
2017-12-31-$490,181.00
2017-09-30$1.82M
2017-06-30-$2.17M$188,130.00-$1.09M-$335,827.00$405,410.00
2017-03-31-$3.19M$209,598.00-$4.08M-$292,922.00$1.68M
2016-12-31$1.67M
2016-09-30$4.24M
2016-06-30$1.09M$176,060.00-$764,172.00
2016-03-31$8.5M$173,836.00$606,426.00
2015-12-31-$12.23M
2015-09-30-$1.68M
2015-06-30$4.73M$161,460.00$1.89M
2015-03-31-$6.35M-$66,650.00-$3.86M
2014-12-31$7.42M
2014-09-30$6.25M
2014-06-30-$2.09M$209,395.00-$4.21M
2014-03-31-$31.48M$119,469.00-$1.48M
2013-12-31-$1.06M
2013-09-30-$9.64M
2013-06-30$921,666.00$109,553.00-$355,047.00-$134,887.00$352,013.00
2013-03-31$1.6M$92,797.00-$476,685.00$54,233.00$725,820.00
2012-12-31$9.36M
2012-09-30$1.05M
2012-06-30-$10.52M$118,442.00-$297,383.00-$71,939.00$175,970.00
2012-03-31-$7.01M$120,609.00$395,016.00-$114,286.00-$181,015.00
2011-12-31$8.76M
2011-09-30$13.92M
2011-06-30-$30.73M$124,934.00$239,089.00-$301,956.00-$3,540.00
2011-03-31-$16.61M$121,092.00$1.23M-$929,752.00$1.11M
2010-12-31$5.93M
2010-09-30$1.86M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-03-31$44.87M$1.07M$23.75M$925,626.00-$925,626.00-$4.32M
2025-03-31-$4.31M$1.23M$7.46M$1.63M-$2.4M-$825,740.00
2024-03-31$20.11M$1.32M-$3.24M$809,653.00-$809,653.00$3.34M
2023-03-31$3.56M$1.28M$3.34M$5.74M-$5.74M$1.7M
2022-03-31$8.9M$1.21M$6.51M$498,566.00-$498,566.00-$667,133.00
2021-03-31$5.09M$1.31M$3.19M-$262,781.00-$869,829.00
2020-03-31-$2.24M$1.32M-$1.79M-$34,953.00$689,536.00
2019-03-31-$9.28M$1.26M-$6.79M$330,870.00$1.57M
2018-03-31-$3.67M$996,406.00-$4.81M-$274,847.00$1.67M
2017-03-31$3.81M$714,530.00-$7.88M-$1.1M$8.07M
2016-03-31-$683,012.00$666,461.00-$2.77M-$1.95M$8.76M
2015-03-31$5.22M$581,855.00-$15.1M
2014-03-31-$41.26M$453,746.00-$4.22M
2013-03-31$1.49M$423,340.00-$1.94M-$191,822.00$1.84M
2012-03-31-$15.06M$484,151.00-$394,082.00-$657,790.00-$105,580.00
2011-03-31-$13.58M$483,473.00$1.55M-$1.35M$1.05M